<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01545700</url>
  </required_header>
  <id_info>
    <org_study_id>EH08-413</org_study_id>
    <nct_id>NCT01545700</nct_id>
  </id_info>
  <brief_title>Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery</brief_title>
  <official_title>Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NorthShore University HealthSystem Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The question of a possible hyperglycemic effect from single-dose dexamethasone is an
      important issue for clinicians managing patients in the intraoperative and postoperative
      periods. Recent evidence suggests that even moderate elevations in blood glucose levels may
      be associated with adverse events.

      The aim of this clinical investigation is to determine whether standard clinical doses of
      dexamethasone produce hyperglycemia in the perioperative period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized on the morning of surgery to one of six groups; dexamethasone 4mg
      groups (0-4 hour group, 8-24 hour group), dexamethasone 8 mg groups (0-4 hour group, 8-24
      hour group), or a placebo group(0-4 hour group, 8-24 hour group). Randomization will be
      performed using the sealed envelope method (on the basis of a block-randomized
      computer-generated list). The drug/placebo solution will be prepared by the pharmacy into a
      syringe (either 2cc of dexamethasone (8mg), 1cc dexamethasone (4mg) + 1cc normal saline, or
      2cc of saline (placebo)) and delivered to one of investigators. All solutions are clear and
      appear identical. Patients in the dexamethasone groups will receive a standard intraoperative
      dose of dexamethasone (either 4mg or 8 mg) intravenously at the induction of anesthesia.
      Patients in the placebo groups will receive 2 cc of saline at induction of anesthesia. Study
      syringes will be prepared by the pharmacy, and all clinicians will be blinded to group
      assignment.

      Primary Outcome Variable Serum Glucose levels: In the 0-4 hour patients, Blood glucose
      concentrations will be measured at 5 time intervals: at induction of anesthesia and at 60,
      120, 180, and 240 minutes after the dexamethasone is administered. In the 8-24 hour patients,
      blood glucose levels will be measured at induction of anesthesia and at at 8- and 24-hours
      after induction. All blood samples will be measured using a portable glucometer which is
      calibrated daily. Blood glucose will be calculated by measuring a fingerprick capillary blood
      sample. The blood samples will be collected while the patient is under anesthesia and
      recovering from surgery.

      Secondary Outcome Variables

        1. Pain scores: Postoperative pain scores will be assessed using 100 mm visual analog scale
           (VAS) in which 0 represents no pain and 100 represents the worst pain imaginable. Pain
           scores will be measured at rest and with movement at 1 and 2 hours following surgery.

        2. Nausea and vomiting scores: The incidence of nausea will be quantified using a verbal
           rating scale (VRS- 0=no nausea, 1=mild nausea, 2=moderate nausea, 3=severe nausea). The
           incidence of vomiting was quantified on a 4-point scale; 0 = (none) no episodes, 1=
           (mild) 1 episode, 2= (moderate) 2-3 episodes, 3= (severe) more than 3 episodes. Nausea
           and vomiting scores will be obtained at discharge from the PACU.

        3. PACU data: Episodes of nausea and vomiting will be recorded. Requirements for pain
           medication and antiemetic medication will be recorded. The time needed to meet discharge
           criteria and achieve actual discharge will be noted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Blood Glucose Concentrations</measure>
    <time_frame>Patient were followed for the duration of hospitalization, for an average of 6 days</time_frame>
    <description>Serum blood glucose concentrations</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>Patients were followed for the duration of hospitalization, for an average of 6 days</time_frame>
    <description>VAS pain scoes at rest 0=no pain, 100=worst pain imaginable</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Control, saline 0-4 hours</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 cc of saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 4 mg, 0-4 hours</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 4 mg administered intraoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 8 mg, 0-4 hours</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 8 mg administered intraoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator saline 8-24 hours</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo, 2 cc saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 4 mg, 8-24 hours</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 4 mg administered intraoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 8 mg, 8-24 hours</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 8 mg administered intraoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control-saline</intervention_name>
    <description>Patients are randomized to receive saline 2 cc</description>
    <arm_group_label>Control, saline 0-4 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 4 mg</intervention_name>
    <description>Patients randomized to receive dexamethasone 4mg and 1 cc saline</description>
    <arm_group_label>Dexamethasone 4 mg, 0-4 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 8 mg</intervention_name>
    <description>Patients randomized to receive dexamethasone 8mg</description>
    <arm_group_label>Dexamethasone 8 mg, 0-4 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control saline</intervention_name>
    <description>Patients are randomized to receive saline 2 cc</description>
    <arm_group_label>Placebo Comparator saline 8-24 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 4 mg</intervention_name>
    <description>Patients are randomized to receive dexamethasone 4 mg and saline 1 cc</description>
    <arm_group_label>Dexamethasone 4 mg, 8-24 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 8 mg</intervention_name>
    <description>Patients are randomized to receive dexamethasone 8 mg</description>
    <arm_group_label>Dexamethasone 8 mg, 8-24 hours</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for elective gynecologic surgery

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 90, patients receiving chronic or preoperative steroids,or allergy to
             dexamethasone.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn S Murphy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <results_first_submitted>November 9, 2012</results_first_submitted>
  <results_first_submitted_qc>December 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 15, 2013</results_first_posted>
  <last_update_submitted>January 15, 2013</last_update_submitted>
  <last_update_submitted_qc>January 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem Research Institute</investigator_affiliation>
    <investigator_full_name>Glenn S. Murphy, MD</investigator_full_name>
    <investigator_title>Director, Cardiac Anesthesia and Clinical Research</investigator_title>
  </responsible_party>
  <keyword>dexamethasone</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>gynecologic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was conducted at NorthShore University HealthSystem (a single tertiary medical center affiliated with the University of Chicago Pritzker School of Medicine) and was registered with ClinicalTrials.gov (NCT #01545700). Participants were recruited by reviewing operating room schedules and contact by telephone on the day before surgery.</recruitment_details>
      <pre_assignment_details>A total of 200 patients were enrolled in this clinical trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control, Saline 0-4 Hours</title>
          <description>2 cc of saline
Control-saline : Patients are randomized to receive saline 2 cc</description>
        </group>
        <group group_id="P2">
          <title>Dexamethasone 4 mg, 0-4 Hours</title>
          <description>Dexamethasone 4 mg administered intraoperatively
Dexamethasone 4 mg : Patients randomized to receive dexamethasone 4mg and 1 cc saline</description>
        </group>
        <group group_id="P3">
          <title>Dexamethasone 8 mg, 0-4 Hours</title>
          <description>Dexamethasone 8 mg administered intraoperatively
Dexamethasone 8 mg : Patients randomized to receive dexamethasone 8mg</description>
        </group>
        <group group_id="P4">
          <title>Placebo Comparator Saline 8-24 Hours</title>
          <description>placebo, 2 cc saline
Control saline : Patients are randomized to receive saline 2 cc</description>
        </group>
        <group group_id="P5">
          <title>Dexamethasone 4 mg, 8-24 Hours</title>
          <description>Dexamethasone 4 mg administered intraoperatively
Dexamethasone 4 mg : Patients are randomized to receive dexamethasone 4 mg and saline 1 cc</description>
        </group>
        <group group_id="P6">
          <title>Dexamethasone 8 mg, 8-24 Hours</title>
          <description>Dexamethasone 8 mg administered intraoperatively
Dexamethasone 8 mg : Patients are randomized to receive dexamethasone 8 mg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="33"/>
                <participants group_id="P4" count="34"/>
                <participants group_id="P5" count="33"/>
                <participants group_id="P6" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="34"/>
                <participants group_id="P5" count="32"/>
                <participants group_id="P6" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control, Saline 0-4 Hours</title>
          <description>2 cc of saline
Control-saline : Patients are randomized to receive saline 2 cc</description>
        </group>
        <group group_id="B2">
          <title>Dexamethasone 4 mg, 0-4 Hours</title>
          <description>Dexamethasone 4 mg administered intraoperatively
Dexamethasone 4 mg : Patients randomized to receive dexamethasone 4mg and 1 cc saline</description>
        </group>
        <group group_id="B3">
          <title>Dexamethasone 8 mg, 0-4 Hours</title>
          <description>Dexamethasone 8 mg administered intraoperatively
Dexamethasone 8 mg : Patients randomized to receive dexamethasone 8mg</description>
        </group>
        <group group_id="B4">
          <title>Placebo Comparator Saline 8-24 Hours</title>
          <description>placebo, 2 cc saline
Control saline : Patients are randomized to receive saline 2 cc</description>
        </group>
        <group group_id="B5">
          <title>Dexamethasone 4 mg, 8-24 Hours</title>
          <description>Dexamethasone 4 mg administered intraoperatively
Dexamethasone 4 mg : Patients are randomized to receive dexamethasone 4 mg and saline 1 cc</description>
        </group>
        <group group_id="B6">
          <title>Dexamethasone 8 mg, 8-24 Hours</title>
          <description>Dexamethasone 8 mg administered intraoperatively
Dexamethasone 8 mg : Patients are randomized to receive dexamethasone 8 mg</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="33"/>
            <count group_id="B4" value="34"/>
            <count group_id="B5" value="33"/>
            <count group_id="B6" value="33"/>
            <count group_id="B7" value="200"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="28"/>
                    <measurement group_id="B7" value="169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" spread="10"/>
                    <measurement group_id="B2" value="53" spread="9"/>
                    <measurement group_id="B3" value="53" spread="11"/>
                    <measurement group_id="B4" value="57" spread="12"/>
                    <measurement group_id="B5" value="53" spread="13"/>
                    <measurement group_id="B6" value="56" spread="11"/>
                    <measurement group_id="B7" value="54" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="33"/>
                    <measurement group_id="B6" value="33"/>
                    <measurement group_id="B7" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="33"/>
                    <measurement group_id="B6" value="33"/>
                    <measurement group_id="B7" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores</title>
        <description>VAS pain scoes at rest 0=no pain, 100=worst pain imaginable</description>
        <time_frame>Patients were followed for the duration of hospitalization, for an average of 6 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo 0-4 Hours</title>
            <description>Placebo 0-4 hours baseline</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 4 mg 0-4 Hours</title>
          </group>
          <group group_id="O3">
            <title>Dexamethasone 8 mg 0-4 Hours</title>
          </group>
          <group group_id="O4">
            <title>Placebo 8-24 Hours</title>
          </group>
          <group group_id="O5">
            <title>Dexamethasone 4 mg 8-24 Hours</title>
          </group>
          <group group_id="O6">
            <title>Dexamethasone 8 mg 8-24 Hours</title>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores</title>
          <description>VAS pain scoes at rest 0=no pain, 100=worst pain imaginable</description>
          <units>0-100 VAS scale scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="34"/>
                <count group_id="O5" value="32"/>
                <count group_id="O6" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" spread="21"/>
                    <measurement group_id="O2" value="47" spread="26"/>
                    <measurement group_id="O3" value="45" spread="24"/>
                    <measurement group_id="O4" value="50" spread="21"/>
                    <measurement group_id="O5" value="45" spread="17"/>
                    <measurement group_id="O6" value="44.5" spread="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum Blood Glucose Concentrations</title>
        <description>Serum blood glucose concentrations</description>
        <time_frame>Patient were followed for the duration of hospitalization, for an average of 6 days</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo 0-4 Hours-baseline</title>
            <description>Placebo 0-4 hours baseline</description>
          </group>
          <group group_id="O2">
            <title>Placebo 0-4 Hours-1 Hour</title>
            <description>Placebo 0-4 hours-1 hour</description>
          </group>
          <group group_id="O3">
            <title>Placebo 0-4 Hours-2 Hours</title>
            <description>Placebo 0-4 hours-2 hours</description>
          </group>
          <group group_id="O4">
            <title>Placebo 0-4 Hours-3 Hours</title>
          </group>
          <group group_id="O5">
            <title>Placebo 0-4 Hours-4 Hours</title>
          </group>
          <group group_id="O6">
            <title>Dexamethasone 4 mg 0-4 Hours-baseline</title>
          </group>
          <group group_id="O7">
            <title>Dexamethasone 4 mg 0-4 Hours-1 Hour</title>
          </group>
          <group group_id="O8">
            <title>Dexamethasone 4 mg 0-4 Hours-2 Hours</title>
          </group>
          <group group_id="O9">
            <title>Dexamethasone 4 mg 0-4 Hours-3 Hours</title>
          </group>
          <group group_id="O10">
            <title>Dexamethasone 4 mg 0-4 Hours-4 Hours</title>
          </group>
          <group group_id="O11">
            <title>Dexamethasone 8 mg 0-4 Hours-baseline</title>
          </group>
          <group group_id="O12">
            <title>Dexamethasone 8 mg 0-4 Hours-1 Hour</title>
          </group>
          <group group_id="O13">
            <title>Dexamethasone 8 mg 0-4 Hours-2 Hours</title>
          </group>
          <group group_id="O14">
            <title>Dexamethasone 8 mg 0-4 Hours-3 Hours</title>
          </group>
          <group group_id="O15">
            <title>Dexamethasone 8 mg 0-4 Hours-4 Hours</title>
          </group>
          <group group_id="O16">
            <title>Placebo 8-24 Hours Baseline</title>
          </group>
          <group group_id="O17">
            <title>Placebo 8-24 Hours-8 Hours</title>
          </group>
          <group group_id="O18">
            <title>Placebo 8-24 Hours-24 Hours</title>
          </group>
          <group group_id="O19">
            <title>Dexamethasone 4 mg 8-24 Hours-baseline</title>
          </group>
          <group group_id="O20">
            <title>Dexamethasone 4 mg 8-24 Hours-8 Hours</title>
          </group>
          <group group_id="O21">
            <title>Dexamethasone 4 mg 8-24 Hours-24 Hours</title>
          </group>
          <group group_id="O22">
            <title>Dexamethasone 8 mg 8-24 Hours-baseline</title>
          </group>
          <group group_id="O23">
            <title>Dexamethasone 8 mg 8-24 Hours-8 Hours</title>
          </group>
          <group group_id="O24">
            <title>Dexamethasone 8 mg 8-24 Hours-24 Hours</title>
          </group>
        </group_list>
        <measure>
          <title>Serum Blood Glucose Concentrations</title>
          <description>Serum blood glucose concentrations</description>
          <population>per protocol</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
                <count group_id="O4" value="33"/>
                <count group_id="O5" value="33"/>
                <count group_id="O6" value="32"/>
                <count group_id="O7" value="32"/>
                <count group_id="O8" value="32"/>
                <count group_id="O9" value="32"/>
                <count group_id="O10" value="32"/>
                <count group_id="O11" value="31"/>
                <count group_id="O12" value="31"/>
                <count group_id="O13" value="31"/>
                <count group_id="O14" value="31"/>
                <count group_id="O15" value="31"/>
                <count group_id="O16" value="34"/>
                <count group_id="O17" value="34"/>
                <count group_id="O18" value="34"/>
                <count group_id="O19" value="32"/>
                <count group_id="O20" value="32"/>
                <count group_id="O21" value="32"/>
                <count group_id="O22" value="33"/>
                <count group_id="O23" value="33"/>
                <count group_id="O24" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101" spread="15"/>
                    <measurement group_id="O2" value="137" spread="29"/>
                    <measurement group_id="O3" value="140" spread="28"/>
                    <measurement group_id="O4" value="141" spread="34"/>
                    <measurement group_id="O5" value="139" spread="34"/>
                    <measurement group_id="O6" value="107" spread="21"/>
                    <measurement group_id="O7" value="141" spread="23"/>
                    <measurement group_id="O8" value="159" spread="33"/>
                    <measurement group_id="O9" value="159" spread="30"/>
                    <measurement group_id="O10" value="159" spread="25"/>
                    <measurement group_id="O11" value="108" spread="23"/>
                    <measurement group_id="O12" value="138" spread="27"/>
                    <measurement group_id="O13" value="151" spread="23"/>
                    <measurement group_id="O14" value="146" spread="22"/>
                    <measurement group_id="O15" value="149" spread="25"/>
                    <measurement group_id="O16" value="101" spread="19"/>
                    <measurement group_id="O17" value="150" spread="36"/>
                    <measurement group_id="O18" value="121" spread="26"/>
                    <measurement group_id="O19" value="98" spread="16"/>
                    <measurement group_id="O20" value="149" spread="28"/>
                    <measurement group_id="O21" value="119" spread="16"/>
                    <measurement group_id="O22" value="100" spread="19"/>
                    <measurement group_id="O23" value="151" spread="36"/>
                    <measurement group_id="O24" value="124" spread="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control-saline Group</title>
        </group>
        <group group_id="E2">
          <title>Dexamethasone Group</title>
          <description>either 4 mg or 8 mg</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="128"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Glenn S. Murphy, MD</name_or_title>
      <organization>NorthShore University HealthSystem</organization>
      <phone>847-570-2760</phone>
      <email>dgmurphy2@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

